PHARMA-SD® Spray Dryer

The comprehensive family of GEA NIRO PHARMA-SD® spray dryers offers the pharmaceutical, biotech, and associated contract manufacturing sectors a versatile, fully scalable line of GMP spray dryers for processing both small molecule pharmaceuticals and biologics.

GEA aseptic spray drying plants
Pharma spray drying process

Aseptic and high-containment spray drying plants

GEA expertise covers the most demanding pharmaceutical powder applications. In addition to our standardized and customizable GEA PSD systems, the GEA ASEPTIC-SD® spray drying plant has been developed to give you confidence in safe, reliable sterile powder manufacturing. We also have global expertise configuring high containment spray drying plants for processing up to the highest potency level (occupational exposure band (OEB) level 5).

GEA drying test facilities

Dedicated pharma spray drying test center

GEA doesn’t just sell equipment. Experts at our European test center for spray drying can work with you to evaluate, optimize and scale up your processes and equipment. At the GEA test center you can configure and test GEA PSD plants, tap into specialist expertise and troubleshoot. You can also work with us to analyze pharmaceutical powder characteristics and properties and integrate upstream and downstream processes.

High containment plants pharma spray drying
Pharma spray drying

Downloads

Related Videos

Powder Talks - Aseptic Spray Drying

GEA Insights

Heat pumps fast-track district heating decarbonization

The impact of global warming is increasingly apparent all over the world. Towns and cities everywhere face the same challenge: providing their communities with reliable, affordable, sustainably sourced heat. GEA spoke with an expert in the field, Kenneth Hoffmann, Manager, Heat Pumps at GEA Heating & Refrigeration Technologies, about tackling global warming faster.

Living the digital future of dairy farming with GEA

Something caught Farmer Tom's eye. Instead of another product demo, GEA showcased innovations via AR. That's only the start of GEA's interactive digital farm.

GEA homogenizers power bioinks for regenerative medicine

GEA scientists are working with researchers at the Graz University of Technology to configure a homogenization process and technology that turns eucalyptus pulp into 3D-printed, organic structures mimicking human veins, arteries and other tissues.

Receive news from GEA

Stay in touch with GEA innovations and stories by signing up for news from GEA.

Need assistance?

We are here to help! With just a few details we will be able to respond to your inquiry.